SBIR/STTR Research Award

Improved Dialysis Cannulation Needle

Award identifier 716f726a6d52624e05f58ce6c19c8fef2917da30ef6dc1e20405189fe9a0aac7Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$314,279

Program and phase

SBIR · Phase I

Award year

2025

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Minnesota HealthSolutions Corporation
Proposal award date
2025-09-12
Contract end date
2026-08-31
UEI
G34WKGPA1M73
Solicitation number
PA24-245
Topic code
400

Research abstract

Project Summary/Abstract The proposed project relates to the development and evaluation of an innovative dialysis cannulation needle that aims to reduce the rate of accidental needle infiltration injury and thereby improve the safety and efficacy of home and in-center renal dialysis therapy. Access to an arterial and venous blood source with adequate blood flow is needed to facilitate hemodialysis. Care and preservation of patent, well-functioning dialysis accesses are among the most difficult clinical problems in the long-term treatment of patients undergoing dialysis and loss of access is frequent. A well-functioning arteriovenous fistula has been recognized as a preferred access modality by the renal community. Dialysis generally requires cannulation with two large-bore needles three-times weekly to achieve blood flow sufficiently high to ensure adequate dialysis and more than 150 million dialysis cannulations are conducted per year in the U.S. alone. Cannulation accuracy with correct needle position is vital to successful access without damage to the arteriovenous fistula. An infiltration injury occurs when the cannulation needle puncture initially enters the vessel but subsequently pierces the vessel wall elsewhere, resulting in a localized subcutaneous hematoma causing pain, swelling, bruising and other physical and psychological impacts on the patient, which often lead to additional testing and interventions. Minor infiltrations are common, occurring in some 50% of patients within the first three dialysis sessions after arteriovenous fistula maturation. Major infiltrations are less common, more consequential, and occur at a rate of 5% annually for all patients with arteriovenous fistula. Six months after a major infiltration, only 65% of patients have resumed use of their arteriovenous fistula. Qualitative studies evaluating barriers to home dialysis, which comes with many benefits, indicate that self-cannulation is a significant source of fear and anxiety. A novel safer needle is proposed that requires no action from the operator and no change to current dialysis workflow to achieve benefit. An advanced prototype needle will be designed, manufactured and tested.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

66 SBIR/STTR records share this UEI (2007–2025). Reported award amounts total $44,761,119. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, Department of Education, National Science Foundation

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.